Korea’s ViroMed acquires DNA-producing facility for clinical trial in U.S.
ViroMed, a Korean developer of biologic drugs, Wednesday announced it has acquired a DNA production facility in San Diego, California, adding a manufacturing function...
Continue Reading →
